| CIVENTICHEM CV-4057 |
拉喹莫德 |
248281-84-7 |
| ADH 1 |
N-钙粘蛋白拮抗剂 |
229971-81-7 |
| Urea, N-[5-chloro-2-[2-[(2R)-4-[(4-fluorophenyl)Methyl]-2-Methyl-1-piperazinyl]-2-oxoethoxy]phenyl]- |
(R)-1-(5-氯-2-(2-(4-(4-氟苄基)-2-甲基哌嗪-1-基)-2-氧代乙氧基)苯基)脲 |
217645-70-0 |
| IXABEPILONE |
伊沙匹隆 |
219989-84-1 |
| NU 6027 |
NU6027 |
220036-08-8 |
| PD184352 |
2-[(2-氯-4-碘苯基)氨基]-N-(环丙基甲氧基)-3,4-二氟-苯甲酰胺 |
212631-79-3 |
| PD 173074 |
PD173074 |
219580-11-7 |
| SRPK inhibitor |
SRPKINHIBITOR |
218156-96-8 |
| Entinostat |
恩替诺特 |
209783-80-2 |
| Sitaxentan sodium |
西他生坦钠 |
210421-74-2 |
| ReModelin hydrobroMide |
REMODELIN |
1622921-15-6 |
| ISRIB (trans-isoMer) |
ISRIB(TRANS-ISOMER) 抑制剂 |
1597403-47-8 |
| NIBR189 |
NIBR189 |
1599432-08-2 |
| SGC0946 |
SGC0946 |
1561178-17-3 |
| XEN445 |
(S)-2-(3-(PYRIDIN-2-YLMETHOXY)PYRROLIDIN-1-YL)-5-(TRIFLUOROMETHYL)BENZOIC ACID. HCL |
1515856-92-4 |
| UNC2025 |
反式-4-[2-(丁基氨基)-5-[4-[(4-甲基-1-哌嗪基)甲基]苯基]-7H-吡咯并[2,3-D]嘧啶-7-基]-环己醇 |
1429881-91-3 |
| JNK-IN-8 |
JNK-IN-8 |
1410880-22-6 |
| Tazemetostat (EPZ-6438) |
EPZ-6438 |
1403254-99-8 |
| 1-Cyclopentyl-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-6-(4-(MorpholinoMethyl)phenyl)-1H-indazole-4-carboxaMide |
EPZ005687 |
1396772-26-1 |
| Verdinexor (KPT-335) |
Verdinexor (KPT-335) |
1392136-43-4 |
QQ
